This page outlines Medinet Inc.'s business operations, which include four main services: specialized cell manufacturing, CDMO business, value chain solutions, and autologous cancer tissue banking. The company manufactures customized cell products under Japan's regenerative medicine safety law, offering immune cell therapies and adipose-derived stem cells for various diseases. The CDMO business provides product development and manufacturing support for regenerative medicine products. The value chain business assists clients through engineer dispatch, facility design, and operational management. The cancer tissue banking service stores surgically resected cancer tissues for dendritic cell vaccine production. Medinet supports medical institutions throughout the regulatory process and implementation of regenerative therapies.
